Pages
81 Results for Therapy Access
-
Therapy Access
-
Health System Specialty Pharmacy Supports Access and Adherence for GLP-1 Receptor Agonists for Patients with Obesity
Insights
Health System Specialty Pharmacy Supports Access and Adherence for GLP-1 Receptor Agonists for Patients with Obesity
This study assesses the impact of an integrated health system specialty pharmacy model on GLP-1 RA access and adherence in adult patients with obesity.
-
Shields Health Solutions
Pages
Shields Health Solutions
-
Solutions
Pages
Solutions
-
Recombinant Human Growth Hormone Therapy Clinical Outcomes at an Integrated Health System Specialty Pharmacy
Insights
Recombinant Human Growth Hormone Therapy Clinical Outcomes at an Integrated Health System Specialty Pharmacy
This study assess the impact of a health system specialty pharmacy program on operational and clinical outcomes for patients on hGH.
-
Shields Health Solutions Brings Integrated Specialty Pharmacy Services to Baptist Health in Jacksonville
News
Shields Health Solutions Brings Integrated Specialty Pharmacy Services to Baptist Health in Jacksonville
The onsite specialty pharmacy will streamline access to medications, enhance care coordination, and improve patient outcomes.
-
Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters
Insights
Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters
With the right partner, you can accelerate your specialty pharmacy program’s potential while retaining full ownership and staying true to your mission. Learn how.
-
Technology
Pages
Technology
-
2025 Specialty Pharmacy Outcomes
Insights
2025 Specialty Pharmacy Outcomes
The 5th Annual Shields Specialty Pharmacy Outcomes Report is here. Featuring results from more than 2 million patients across 50+ integrated disease states and nearly 80 health system partners.
-
Revised 340B Rebate Model Pilot Program: What Covered Entities Need to Know for 2027
Insights
Revised 340B Rebate Model Pilot Program: What Covered Entities Need to Know for 2027
Starting January 1, 2027, the 340B landscape may shift following the Health Resources and Services Administration’s (HRSA) implementation of the revised 340B Rebate Model Pilot Program (“Pilot Program
-
Introducing Connected Performance: A Better Approach for Specialty Care
Insights
Introducing Connected Performance: A Better Approach for Specialty Care
Improve specialty outcomes and access to therapy with Shields’ platform that combines embedded clinical expertise with AI-enabled automation and intelligent workflows to drive connected performance.
-
Operational Rigor
Pages
Operational Rigor